
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Haoxi Health Technology Limited Class A Ordinary Shares (HAO)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: HAO (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -18.9% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.77M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.28 | 52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 |
52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.85 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.61% | Operating Margin (TTM) -0.53% |
Management Effectiveness
Return on Assets (TTM) 3.42% | Return on Equity (TTM) 2.92% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -4130603 | Price to Sales(TTM) 0.08 |
Enterprise Value -4130603 | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA 17.37 | Shares Outstanding 2205800 | Shares Floating 1686284 |
Shares Outstanding 2205800 | Shares Floating 1686284 | ||
Percent Insiders 21.79 | Percent Institutions 5.78 |
Upturn AI SWOT
Haoxi Health Technology Limited Class A Ordinary Shares

Company Overview
History and Background
Haoxi Health Technology Limited Class A Ordinary Shares operates within the telehealth and online healthcare services sector, primarily focusing on the Chinese market. Details regarding its founding year and specific milestones require further research due to limited publicly available information.
Core Business Areas
- Online Pharmacy: Providing a platform for purchasing prescription and over-the-counter medications online.
- Telemedicine Consultations: Connecting patients with doctors and specialists for remote medical consultations.
- Health Information and Education: Offering health-related content and educational resources to users.
Leadership and Structure
Information regarding the specific leadership team and organizational structure of Haoxi Health Technology Limited Class A Ordinary Shares is not readily available. Further research and company filings would be needed.
Top Products and Market Share
Key Offerings
- Online Prescription Refills: Facilitating the refill of prescriptions through its online platform. Market share data is difficult to determine specifically for Haoxi Health due to limited public information. Competitors include Ali Health (0241.HK) and JD Health (6618.HK).
- Virtual Doctor Consultations: Offering virtual consultations with healthcare professionals. Market share data is difficult to determine specifically for Haoxi Health due to limited public information. Competitors include Ali Health (0241.HK) and JD Health (6618.HK).
Market Dynamics
Industry Overview
The telehealth and online healthcare market is experiencing rapid growth, driven by increasing internet penetration, rising healthcare costs, and a growing demand for convenient healthcare solutions. The regulatory landscape is evolving, and competition is intensifying.
Positioning
Haoxi Health Technology Limited Class A Ordinary Shares aims to establish a strong presence in the Chinese online healthcare market. Competitive advantages may include partnerships with hospitals and pharmacies, and technological innovation.
Total Addressable Market (TAM)
The total addressable market for online healthcare in China is estimated to be significant, projected to reach hundreds of billions of US dollars in the coming years. Haoxi Health is positioned to capture a portion of this TAM by offering convenient and accessible online healthcare services. Details on exact TAM are dependent on scope and year of analysis.
Upturn SWOT Analysis
Strengths
- Growing demand for online healthcare services
- Potential partnerships with established healthcare providers
- Technological capabilities in developing online platforms
Weaknesses
- Limited brand recognition compared to larger competitors
- Dependence on regulatory approvals
- Potential data security and privacy concerns
Opportunities
- Expansion into new healthcare services
- Geographic expansion within China
- Strategic acquisitions of complementary businesses
Threats
- Intense competition from established players
- Changes in government regulations
- Economic slowdown in China
Competitors and Market Share
Key Competitors
- Ali Health (0241.HK)
- JD Health (6618.HK)
- Ping An Good Doctor (1833.HK)
Competitive Landscape
Haoxi Health faces intense competition from larger, more established players in the Chinese online healthcare market. To succeed, the company needs to differentiate itself through innovative services, strategic partnerships, and effective marketing.
Growth Trajectory and Initiatives
Historical Growth: Due to data limitations, a detailed historical growth analysis is not possible.
Future Projections: Analyst estimates for Haoxi Health Technology Limited Class A Ordinary Shares's future growth are unavailable. Future projection are dependant on the current economic and political standing.
Recent Initiatives: Information regarding recent strategic initiatives undertaken by Haoxi Health Technology Limited Class A Ordinary Shares is limited.
Summary
Haoxi Health Technology Limited aims to capitalize on the growing demand for online healthcare in China. However, the company faces significant competition from larger players and needs to strengthen its brand and secure regulatory approvals. Strategic partnerships and innovative services will be crucial for success. Further financial data is required for a comprehensive analysis.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Various financial news sources
- Industry reports
- Company website (if available)
Disclaimers:
The information provided is for general informational purposes only and should not be construed as financial advice. The data may be incomplete or inaccurate due to limited availability of public information. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Haoxi Health Technology Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2008-01-30 | Chairman & CEO Mr. Zhen Fan | ||
Sector Communication Services | Industry Advertising Agencies | Full time employees 30 | Website https://www.haoximedia.com |
Full time employees 30 | Website https://www.haoximedia.com |
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. The company serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.